Literature DB >> 20024687

Selective retina therapy (SRT) in patients with geographic atrophy due to age-related macular degeneration.

Philipp Prahs1, Andreas Walter, Roman Regler, Dirk Theisen-Kunde, Reginald Birngruber, Ralf Brinkmann, Carsten Framme.   

Abstract

BACKGROUND: For geographic atrophy (GA) due to age-related macular degeneration (AMD) there is so far no approved treatment option. Usually, increased autofluorescence (AF) levels of different patterns adjacent to the atrophic area indicate lipofuscin-laden retinal pigment epithelium (RPE) cells at a high risk for apoptosis. Herein, SRT was used to selectively treat these cells to stimulate RPE proliferation, in order to reduce or ideally stop further growth of the atrophic area.
MATERIAL AND METHODS: Six eyes of six patients with bilateral equally pronounced GA were treated by SRT, while the fellow eye served as control. Irradiation was performed using a prototype SRT laser (Medical Laser Center Lübeck, Nd:YLF laser; 527 nm; 200 ns/1.7 micros pulse duration; 30 repetitive pulses at 100 Hz). Test lesions with increasing energies were applied at the lower vessel arcade to determine the individual angiographic and ophthalmoscopic threshold radiant exposures. Treatment was then performed in the area of increased AF adjacent to the GA using energies between both thresholds. The GA progression rates of treated and fellow eyes were evaluated.
RESULTS: After a 1-year follow-up, a progression of the atrophic area was observed in the treated eyes (0.7-8.0 mm(2)/yr, mean 3.0 mm(2)/yr; 46%/yr) whereas the progression rates of the fellow eyes were insignificantly lower (0.46-4.04 mm(2)/yr, mean 1.9 mm(2)/yr; 30%/yr; p = 0.134). The progression rate in the treated eyes of two patients increased significantly, while in the other four patients, the progression rates were nearly the same between both eyes. Moreover, one of these two eyes showed an unexpected RPE reaction after treatment, since all laser lesions led to RPE atrophy and thus an accelerated enlargement of the GA occurred.
CONCLUSION: SRT in the hyperautofluorescent areas of GA was not able to stop or slow down the progression of GA. However, modified treatment strategies might be more promising, e.g. placing the spots outside the hyperautofluorescent areas where RPE apoptosis is postulated. Moreover, SRT studies on GA might be more successfully performed on specific subgroups of GA, based on autofluorescence and other findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024687     DOI: 10.1007/s00417-009-1208-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Authors:  F G Holz; C Bellman; S Staudt; F Schütt; H E Völcker
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

2.  RPE in perfusion tissue culture and its response to laser application. Preliminary report.

Authors:  Carsten Framme; Karin Kobuch; Elfriede Eckert; Jan Monzer; Johann Roider
Journal:  Ophthalmologica       Date:  2002 Sep-Oct       Impact factor: 3.250

3.  Selective retina therapy in patients with central serous chorioretinopathy.

Authors:  H Elsner; E Pörksen; C Klatt; A Bunse; D Theisen-Kunde; R Brinkmann; R Birngruber; H Laqua; J Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

4.  Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study.

Authors:  J Roider; R Brinkmann; C Wirbelauer; H Laqua; R Birngruber
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 5.  Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results.

Authors:  R Brinkmann; J Roider; R Birngruber
Journal:  Bull Soc Belge Ophtalmol       Date:  2006

6.  Comparison of threshold irradiances and online dosimetry for selective retina treatment (SRT) in patients treated with 200 nanoseconds and 1.7 microseconds laser pulses.

Authors:  Carsten Framme; Andreas Walter; Philipp Prahs; Dirk Theisen-Kunde; Ralf Brinkmann
Journal:  Lasers Surg Med       Date:  2008-11       Impact factor: 4.025

Review 7.  Lipofuscin of the retinal pigment epithelium: a review.

Authors:  C J Kennedy; P E Rakoczy; I J Constable
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

8.  The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Stacy M Meuer; Michael D Knudtson; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

9.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Stacy M Meuer; Guan-Hua Huang
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

Review 10.  The epidemiology of age-related macular degeneration.

Authors:  Ronald Klein; Tunde Peto; Alan Bird; Mylan R Vannewkirk
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

View more
  11 in total

1.  Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry.

Authors:  Annal D Meleth; Pradeep Mettu; Elvira Agrón; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

2.  Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Authors:  Wai T Wong; Waynekid Kam; Denise Cunningham; Molly Harrington; Keri Hammel; Catherine B Meyerle; Catherine Cukras; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

Review 3.  Dry age-related macular degeneration: A currently unmet clinical need.

Authors:  Jean-François Girmens; José-Alain Sahel; Katia Marazova
Journal:  Intractable Rare Dis Res       Date:  2012-08

Review 4.  Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.

Authors:  Giuseppe Querques; Maria Vittoria Cicinelli; Alessandro Rabiolo; Luigi de Vitis; Riccardo Sacconi; Lea Querques; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-25       Impact factor: 3.117

5.  Morphologic changes in the retina after selective retina therapy.

Authors:  Ji Ho Yang; Seung-Young Yu; Tae Gi Kim; Eung Suk Kim; Hyung Woo Kwak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-18       Impact factor: 3.117

6.  Comparison of the neuroinflammatory responses to selective retina therapy and continuous-wave laser photocoagulation in mouse eyes.

Authors:  Jung Woo Han; Juhye Choi; Young Shin Kim; Jina Kim; Ralf Brinkmann; Jungmook Lyu; Tae Kwann Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-10       Impact factor: 3.117

7.  Safety and efficacy of selective retina therapy (SRT) for the treatment of diabetic macular edema in Korean patients.

Authors:  Young Gun Park; Jae Ryun Kim; Seungbum Kang; Eric Seifert; Dirk Theisen-Kunde; Ralf Brinkmann; Young-Jung Roh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-23       Impact factor: 3.117

8.  Retinal pigment epithelial responses based on the irradiation density of selective retina therapy.

Authors:  Seung Hee Jeon; Minhee Kim; Young-Jung Roh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-14       Impact factor: 3.117

9.  Functional recovery after experimental RPE debridement, mfERG studies in a porcine model.

Authors:  Nina Buus Sørensen; Nathan Lassota; Maria Voss Kyhn; Jan Ulrik Prause; Klaus Qvortrup; Morten la Cour; Jens Kiilgaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-11       Impact factor: 3.117

10.  Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study.

Authors:  Seungbum Kang; Young Gun Park; Jae Ryun Kim; Eric Seifert; Dirk Theisen-Kunde; Ralf Brinkmann; Young Jung Roh
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.